Methylphenidate Chewable Tablets and Pasireotide Subcutaneous
Determining the interaction of Methylphenidate Chewable Tablets and Pasireotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Chewable Tablets-Patanase
- Methylphenidate Chewable Tablets-Patiromer
- Methylphenidate Chewable Tablets-Patiromer Sorbitex Calcium
- Methylphenidate Chewable Tablets-Pavacot
- Methylphenidate Chewable Tablets-Paxil
- Methylphenidate Chewable Tablets-Paxil (Paroxetine Suspension)
- Pasireotide Subcutaneous-Methylphenidate Controlled-Release Tablets
- Pasireotide Subcutaneous-Methylphenidate ER Capsules
- Pasireotide Subcutaneous-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Pasireotide Subcutaneous-Methylphenidate Extended-Release Chewable Tablets
- Pasireotide Subcutaneous-Methylphenidate Extended-Release Oral Suspension
- Pasireotide Subcutaneous-Methylphenidate Extended-Release Oral-Disintegrating Tablets